In 2023, the share of US scientific publications among the world's top 10% cited in biomedical engineering reached a notable benchmark. However, the forecast indicates a declining trend from 2024, starting at 10.43%, reducing to 8.78% by 2028. This represents a consistent year-on-year decrease. The average compound annual growth rate (CAGR) over the five-year period shows a significant downturn, highlighting a consistent decline in the share of top-cited biomedical engineering publications from the US.

Future trends to watch for include:

The increasing competition from other countries in high-impact biomedical engineering research.
Potential shifts in research funding and priorities affecting publication output quality.
Technological advancements that may influence research dissemination and citation patterns.